Maureen Jonas' research focuses on liver disease in children, with emphasis on viral hepatitis. She was the principal investigator in the multicenter International Pediatric Lamivudine Trial, and is currently studying the safety and efficacy of other drugs, adefovir dipivoxil and entecavir, in children with chronic hepatitis B. She is the principle site investigator for PEDS-C, an NIH sponsored study of the treatment of chronic hepatitis C in children. Other research involves looking at non-invasive ways to detect and measure fibrosis (scarring) in the liver, and some of the metabolic effects of chronic hepatitis C. She participates in an international epidemiologic study of hepatitis B in children, and the national Studies of Pediatric Liver Transplantation (SPLIT.)


Maureen Jonas received her MD degree from University of Miami School of Medicine. She completed internship and residency in General Pediatrics, and fellowship in Pediatric Gastroenterology, at Boston Children's Hospital. She is certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology. Dr. Jonas has served on the Executive Council of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and numerous committees of the American Association for the Study of Liver Diseases. She is a member of the Medical Advisory Committee of the New England Chapter of the American Liver Foundation. She is the director of the Center for Childhood Liver Disease and the Medical Director of the Liver Transplant Program at Boston Children’s Hospital. She is also the Director of the 4th year Advanced Hepatology Fellowship at Children’s. Dr. Jonas recently edited a book on Viral Hepatitis in Children.


Publications powered by Harvard Catalyst Profiles

  1. Utilization of the Boston Children's Hospital SRTR Cohort Visualization Tool to increase team understanding of reporting cohorts. Pediatr Transplant. 2021 Aug 19; e14117. View abstract
  2. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. Hepatology. 2021 Jul; 74(1):19-27. View abstract
  3. Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study. Hepatology. 2021 May 18. View abstract
  4. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology. 2021 03; 73(3):1061-1073. View abstract
  5. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection. J Pediatr. 2021 04; 231:110-116. View abstract
  6. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology. 2021 03; 73(3):1074-1087. View abstract
  7. Graves' disease in a five-month-old boy with an unusual treatment course. J Pediatr Endocrinol Metab. 2021 Mar 26; 34(3):401-406. View abstract
  8. Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat? J Infect Dis. 2020 11 27; 222(Suppl 9):S789-S793. View abstract
  9. Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a. Adv Ther. 2020 07; 37(7):3299-3310. View abstract
  10. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant. 2020 09; 24(6):e13736. View abstract
  11. Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant. Hepatology. 2020 04; 71(4):1474-1485. View abstract
  12. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721. View abstract
  13. Esophageal Capsule Endoscopy in Children and Young Adults With Portal Hypertension. J Pediatr Gastroenterol Nutr. 2019 12; 69(6):641-647. View abstract
  14. Effect of Universal Infant Hepatitis B Virus Immunization on Mother-to-Child Hepatitis B Virus Transmission. J Infect Dis. 2019 08 30; 220(7):1089-1090. View abstract
  15. Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection. Hepatology. 2020 01; 71(1):31-43. View abstract
  16. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study. Hepatology. 2020 02; 71(2):456-462. View abstract
  17. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 06; 4(6):477-487. View abstract
  18. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 06; 4(6):466-476. View abstract
  19. Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia. J Pediatr Gastroenterol Nutr. 2019 02; 68(2):175-181. View abstract
  20. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis. J Cyst Fibros. 2019 03; 18(2):280-285. View abstract
  21. Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Hepatology. 2018 12; 68(6):2158-2166. View abstract
  22. Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now. Clin Infect Dis. 2018 10 30; 67(10):1493-1497. View abstract
  23. Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4. Hepatol Commun. 2018 Nov; 2(11):1311-1319. View abstract
  24. Reply. Hepatology. 2018 10; 68(4):1658-1660. View abstract
  25. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018 Jul; 12(1):33-34. View abstract
  26. Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. J Pediatr. 2018 07; 198:84-89.e2. View abstract
  27. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 04; 67(4):1560-1599. View abstract
  28. Liver Failure as the Presentation of Ornithine Transcarbamylase Deficiency in a 13-Month-Old Female. JIMD Rep. 2018; 40:17-22. View abstract
  29. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2017 10; 66(4):1102-1110. View abstract
  30. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection. Hepatology. 2017 08; 66(2):371-378. View abstract
  31. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):505-511. View abstract
  32. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):512-517. View abstract
  33. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):639-652. View abstract
  34. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):603-609. View abstract
  35. ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016. Intensive Care Med Exp. 2016 Sep; 4(Suppl 1):28. View abstract
  36. Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report. Transplant Proc. 2016 Jun; 48(5):1855-7. View abstract
  37. Outcomes after discontinuation of routine use of transanastomotic biliary stents in pediatric liver transplantation at a single site. Pediatr Transplant. 2016 Aug; 20(5):647-51. View abstract
  38. Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. J Pediatr. 2016 06; 173:160-164.e1. View abstract
  39. Durability of Response in Children Treated With Pegylated Interferon alfa [corrected] 2a ± Ribavirin for Chronic Hepatitis C. J Pediatr Gastroenterol Nutr. 2016 Jan; 62(1):93-6. View abstract
  40. Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis. Hepatology. 2016 Jan; 63(1):307-18. View abstract
  41. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan; 63(1):261-83. View abstract
  42. Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B. Hepatology. 2016 Feb; 63(2):377-87. View abstract
  43. Hepatitis C: Issues in Children. Gastroenterol Clin North Am. 2015 Dec; 44(4):901-9. View abstract
  44. Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis. Am J Surg Pathol. 2015 Jun; 39(6):772-8. View abstract
  45. Treating HCV infection in children. Clin Liver Dis (Hoboken). 2015 Jan; 5(1):14-16. View abstract
  46. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View abstract
  47. Correlates of adiponectin in hepatitis C-infected children: the importance of body mass index. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):165-70. View abstract
  48. Long-term growth outcomes in children treated for chronic hepatitis C. J Pediatr. 2014 Dec; 165(6):1252-4. View abstract
  49. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View abstract
  50. Sonography-guided percutaneous liver biopsies in children. AJR Am J Roentgenol. 2013 Sep; 201(3):645-50. View abstract
  51. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. J Pediatr. 2013 Oct; 163(4):1058-64.e2. View abstract
  52. A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children. Child Obes. 2013 Jun; 9(3):252-60. View abstract
  53. Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):304-10. View abstract
  54. Hepatitis B virus infection in children. Clin Liver Dis (Hoboken). 2013 Feb; 2(1):41-44. View abstract
  55. Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology. 2012 Aug; 56(2):523-31. View abstract
  56. Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys. J Pediatr. 2012 Nov; 161(5):915-21. View abstract
  57. Multivisceral transplantation using a 2.9 kg neonatal donor. Pediatr Transplant. 2012 Dec; 16(8):E379-82. View abstract
  58. Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2012 Jun; 31(6):578-82. View abstract
  59. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin. J Viral Hepat. 2012 Apr; 19(4):263-70. View abstract
  60. Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Hepatology. 2011 May; 53(5):1468-75. View abstract
  61. Hepatitis A virus infection: progress made, more work to be done. J Pediatr (Rio J). 2011 May-Jun 8; 87(3):185-6. View abstract
  62. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology. 2011 Feb; 140(2):450-458.e1. View abstract
  63. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010 Dec; 52(6):2192-205. View abstract
  64. Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):191-7. View abstract
  65. Combined en bloc liver-double kidney transplantation in an infant with IVC thrombosis. Pediatr Transplant. 2011 Nov; 15(7):E142-4. View abstract
  66. Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics. 2009 Nov; 124(5):e1007-13. View abstract
  67. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr. 2009 Mar; 48(3):341-7. View abstract
  68. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009 Jan; 29 Suppl 1:133-9. View abstract
  69. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica. 2008 Aug; 93(8):1247-51. View abstract
  70. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer. 2008 Jul 08; 99(1):100-9. View abstract
  71. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology. 2008 Jun; 47(6):1863-71. View abstract
  72. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma. J Pediatr Surg. 2008 Jun; 43(6):1148-52. View abstract
  73. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa. J Pediatr. 2008 Aug; 153(2):247-53. View abstract
  74. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology. 2008 Mar; 47(3):836-43. View abstract
  75. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety. J Viral Hepat. 2008 Jan; 15(1):20-7. View abstract
  76. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr. 2007 Sep; 151(3):255-9. View abstract
  77. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2007 May; 23(3):306-9. View abstract
  78. Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome. J Pediatr Surg. 2007 May; 42(5):800-5. View abstract
  79. Finding adolescents and young adults with transfusion-associated hepatitis C: looking forward to looking back. Arch Pediatr Adolesc Med. 2007 Feb; 161(2):202-3. View abstract
  80. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. Transplant Proc. 2006 Dec; 38(10):3552-5. View abstract
  81. Treatment of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr. 2006 Jul; 43 Suppl 1:S56-60. View abstract
  82. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006 May; 148(5):652-658. View abstract
  83. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis. 2006 Feb; 10(1):133-48, vii. View abstract
  84. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology. 2006 Feb; 43(2):225-32. View abstract
  85. Review. Gastroenterol Hepatol (N Y). 2006 Feb; 2(2):90. View abstract
  86. Treatment of hereditary hemochromatosis, Wilson Disease, and other metabolic disorders of the liver. Therapy in Digestive Diseases (MM Wolfe, ed.). 2006; 487-502. View abstract
  87. Hepatitis B and C in Children: Current treatment and future strategies. Clinics in Liver Disease (J Bezerra and WF Balistreri, eds.). 2006; 10:133-148. View abstract
  88. The role of liver transplantation in cystic fibrosis re-examined. Liver Transpl. 2005 Dec; 11(12):1463-5. View abstract
  89. [On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data]. Unfallchirurg. 2005 Nov; 108(11):927-8, 930-37. View abstract
  90. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology. 2005 Nov; 42(5):1010-8. View abstract
  91. Mesogonadal shunts for extrahepatic portal vein thrombosis and variceal hemorrhage. Liver Transpl. 2005 Nov; 11(11):1389-94. View abstract
  92. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2005 May; 21(3):344-7. View abstract
  93. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transpl. 2005 Jan; 11(1):108-10. View abstract
  94. Management of hepatitis B infection in children. UpToDate (CD ROM) (BD Rose, ed.). 2005. View abstract
  95. Histopathology of the liver in children with chronic hepatitis B (abstract). Modern Pathology. 2005; 18:312. View abstract
  96. Histopathologic features of chronic hepatitis B in children (abstract). Hepatology. 2005; 42 (suppl):478-9(A). View abstract
  97. Primary sclerosing cholangitis: a clinicopathologic study in 31 children (abstract). Modern Pathology. 2005; 18:305. View abstract
  98. Hepatitis C virus infectionin children. UpToDate (CD ROM) (BD Rose, ed.). 2005. View abstract
  99. Treatment Options for Hepatitis C Infection in Children. Curr Treat Options Gastroenterol. 2004 Oct; 7(5):373-379. View abstract
  100. Acute and chronic hepatitis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 2:S584-8. View abstract
  101. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2004 May; 23(5):441-5. View abstract
  102. Management of hepatitis B in children. Clin Liver Dis. 2004 May; 8(2):387-401. View abstract
  103. Nonalcoholic fatty liver disease. Adolesc Med Clin. 2004 Feb; 15(1):159-73, xi. View abstract
  104. Hepatitis C. Textbook of Pediatric Infectious Diseases (RD Feigin, JD Cherry, GJ Demmler, and S Kaplan, eds.). 2004; 2237-51. View abstract
  105. Hepatitis B and Hepatitis D. Textbook of Pediatric Infectious Diseases (RD Feigin, JD Cherry, GJ Demmler, and S Kaplan, eds.). 2004; 1863-83. View abstract
  106. Hepatitis C in Children. Management Issues in Hepatitis C Infection (JG McHutchison ed.). 2004; 104-7. View abstract
  107. Hepatitis C in Children. Hepatol Rev. 2004; 1:32-8. View abstract
  108. Management of Hepatitis B in Children. Clinics in Liver Disease (TT Tran and P Martin, eds.). 2004; 387-401. View abstract
  109. Working Group Report on Acute and Chronic Hepatitis. J Pediatr Gastroenterol Nutr. 2004; 39:S584-8. View abstract
  110. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2003 May; 19(3):276-80. View abstract
  111. Hepatitis B in children. Semin Liver Dis. 2003 Feb; 23(1):59-68. View abstract
  112. Hepatobilary System. Rudolph's Pediatrics (C Rudolph, ed.). 2003; 1469-1518. View abstract
  113. Liver Disease in Infancy and Childhood. Diseases of the Liver (ER Schiff and M Sorell, eds.). 2003; 1459-98. View abstract
  114. Children with hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S173-8. View abstract
  115. Re: ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr. 2002 Sep; 35(3):399-400; author reply 400. View abstract
  116. Concerns about experimental design. J Pediatr Gastroenterol Nutr. 2002 Aug; 35(2):234. View abstract
  117. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002 May 30; 346(22):1706-13. View abstract
  118. Children with Hepatitis C. Hepatology (Proceedings of NIH Consensus Conference on Hepatitis C). 2002; 36 (Suppl):S173-8. View abstract
  119. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin Immunol. 2001 Dec; 101(3):284-8. View abstract
  120. Challenges in the treatment of hepatitis C in children. Clin Liver Dis. 2001 Nov; 5(4):1063-71. View abstract
  121. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum. 2001 Aug; 44(8):1074-8. View abstract
  122. Anal Fissure. Gastroenterol Clin North Am. 2001 Mar; 30(1):167-81. View abstract
  123. Transcytosis of gastrointestinal epithelial cells by Escherichia coli K1. Pediatr Res. 2001 Jan; 49(1):30-7. View abstract
  124. A 17-year-old girl with vomiting, jaundice and weight loss. Case records of the Massachusetts General Hospital. N Engl J Med. 2001; 344:591-9. View abstract
  125. Fibrocystic Liver Diseases. Liver Disease in Children (FJ Suchy, RJ Sokol, and WF Balistreri, eds.). 2001; 899-913. View abstract
  126. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood. 2001 Jan 01; 97(1):147-53. View abstract
  127. Image of the month. Diagnosis of cutis laxa. Gastroenterology. 2000 Dec; 119(6):1430;1804. View abstract
  128. Viral hepatitis. From prevention to antivirals. Clin Liver Dis. 2000 Nov; 4(4):849-77. View abstract
  129. Treatment of genetic hemochromatosis, Wilson Disease, and other metabolic diseases of the liver. Therapy of Digestive Disorders (MM Wolfe, ed.). 2000; 257-88. View abstract
  130. Hepatitis C in Children. Hepatitis C (TJ Liang and JH Hoofnagle, eds.). 2000; 389-403. View abstract
  131. Viral Hepatitis- From Prevention to Antivirals. Clinics in Liver Disease (JA Bezerra and WF Balistreri, eds.). 2000; 849-77. View abstract
  132. Sources of viral hepatitis in children. Viral Hepatitis Rev. 2000; 6:47-64. View abstract
  133. Treatment of chronic hepatitis C in pediatric patients. Clin Liver Dis. 1999 Nov; 3(4):855-67. View abstract
  134. Hepatitis C infection in children. N Engl J Med. 1999 Sep 16; 341(12):912-3. View abstract
  135. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 1999 Aug; 42(Suppl 1):A1-A330. View abstract
  136. Long-term results in pediatric ABO-incompatible liver transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):467-8. View abstract
  137. A new technique for measuring cardiac output and shunt fraction during venovenous extracorporeal membrane oxygenation. Perfusion. 1999 Jan; 14(1):43-7. View abstract
  138. Neonatal Hepatitis. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 1999; 553-67. View abstract
  139. The locus of tumor necrosis factor-alpha action in lung inflammation. Am J Respir Cell Mol Biol. 1998 Dec; 19(6):881-91. View abstract
  140. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. Am J Gastroenterol. 1998 Dec; 93(12):2544-6. View abstract
  141. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1132-6. View abstract
  142. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology. 1998 Nov; 28(5):1416-23. View abstract
  143. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun. 1998 Oct; 66(10):4932-41. View abstract
  144. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology. 1998 Sep; 115(3):743-6. View abstract
  145. Elevated galactose in newborn screening due to congenital absence of the portal vein. Eur J Pediatr. 1998 Jul; 157(7):608-9. View abstract
  146. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J. 1998 Mar; 17(3):241-6. View abstract
  147. MR cholangiography in children after liver transplantation from living related donors. AJR Am J Roentgenol. 1998 Mar; 170(3):683-7. View abstract
  148. In vitro evaluation of a new lithium dilution method of measuring cardiac output and shunt fraction in patients undergoing venovenous extracorporeal membrane oxygenation. Crit Care Med. 1998 Jan; 26(1):174-7. View abstract
  149. Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest. 1998 Jan 01; 101(1):128-36. View abstract
  150. Biliary Atresia. Clinical Pediatric Gastroenterology (S Altschuler and C Liacouras, eds.). 1998; 331-9. View abstract
  151. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun. 1997 Dec; 65(12):5074-81. View abstract
  152. Image of the month. Disseminated infections, especially candidiasis in immunocompromised individuals, cat-scratch fever, and infiltrative diseases such as leukemia or lymphoma. Gastroenterology. 1997 Nov; 113(5):1432, 1815. View abstract
  153. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr. 1997 Sep; 25(3):321-6. View abstract
  154. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr. 1997 Aug; 131(2):314-6. View abstract
  155. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA. 1996 Nov 20; 276(19):1563-7. View abstract
  156. Isoniazid hepatotoxicity after orthotopic liver transplantation. Mt Sinai J Med. 1996 Oct-Nov; 63(5-6):364-9. View abstract
  157. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun. 1996 Oct; 64(10):4054-9. View abstract
  158. Interferon-alpha for viral hepatitis. J Pediatr Gastroenterol Nutr. 1996 Aug; 23(2):93-106. View abstract
  159. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics. 1996 Aug; 98(2 Pt 1):211-5. View abstract
  160. Long-term hepatic regeneration and function in infants and children following liver resection. J Am Coll Surg. 1996 Jun; 182(6):515-9. View abstract
  161. Hepatitis C infection in children who received extracorporeal membrane oxygenation. J Pediatr Surg. 1996 May; 31(5):644-8. View abstract
  162. Update on viral hepatitis in children. Pediatr Clin North Am. 1996 Feb; 43(1):57-74. View abstract
  163. Hepatitis C virus infection: clinical aspects and treatment with interferon alfa. Clin Ther. 1996; 18 Suppl B:110-25. View abstract
  164. Intravenous immunoglobulin and hepatitis C virus: the Boston episode. Clin Ther. 1996; 18 Suppl B:108-9. View abstract
  165. Clinical features of liver disease. Practical Pediatric Gastroenterology (JA Walker-Smith, JR Hamilton, and WA Walker, eds.). 1996; 107-18. View abstract
  166. Hepatitis C virus infection: clinical aspects and treatment with interferon-alfa. Clin Therapeut. 1996; 18 (Suppl):110-25. View abstract
  167. Hepatitis B vaccination in pediatric practice. Infectious Disease in Children. 1996; 7-13. View abstract
  168. Viral hepatitis. Pediatric Gastrointestinal Disease (WA Walker, PR Durie, JR Hamilton, JA Walker-Smith, and JB Watkins, eds.). 1996; 1028-51. View abstract
  169. The clinical spectrum of hepatitis C virus infection. Internat Semin Paediatr Gastroenterol Nutr. 1996; 5:9-15. View abstract
  170. Closing in on a "familial cholestasis gene". Hepatology. 1995 Nov; 22(5):1611-3. View abstract
  171. Adolescent Human Immunodeficiency Virus Infection and Gastrointestinal Disease. Adolesc Med. 1995 Oct; 6(3):397-416. View abstract
  172. Hereditary hemorrhagic telangiectasia. J Pediatr Gastroenterol Nutr. 1995 Feb; 20(2):238. View abstract
  173. Shedding light into the black box of childhood cholestatic liver disease. Hepatology. 1995 Jan; 21(1):257-60. View abstract
  174. Combined cystic disease of the liver and kidney. Semin Liver Dis. 1994 Aug; 14(3):215-28. View abstract
  175. Hereditary hemorrhagic telangiectasia presenting in early childhood. J Pediatr Gastroenterol Nutr. 1994 May; 18(4):497-500. View abstract
  176. Coombs-positive autoimmune hemolytic anemia and postinfantile giant cell hepatitis in children. Pediatr Pathol. 1994 Jan-Feb; 14(1):69-77. View abstract
  177. Hepatitis B infection in Children. AAP Pediatric Update (monograph and audiocassette) (WF Balistreri, moderator). 1994. View abstract
  178. Hepatic retransplantation in New England--a regional experience and survival model. Transplantation. 1993 Apr; 55(4):802-6. View abstract
  179. Disorders of the biliary tree. Gellis and Kagan's Current Pediatric Therapy (FD Burg, J Ingelfinger, and E Wald, eds.). 1993. View abstract
  180. Bacterial overgrowth in the small bowel. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management (R Wyllie and J Hyams, eds.). 1993. View abstract
  181. Hepatitis C infection in a pediatric dialysis population. Pediatrics. 1992 Apr; 89(4 Pt 2):707-9. View abstract
  182. Congenital diabetes mellitus and fatal secretory diarrhea in two infants. J Pediatr Gastroenterol Nutr. 1991 Nov; 13(4):415-25. View abstract
  183. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa. J Pediatr. 1991 Nov; 119(5):818-20. View abstract
  184. Isolated splenic vein thrombosis as a cause of massive upper-gastrointestinal bleeding following orthotopic liver transplantation. Transplantation. 1991 Oct; 52(4):725-7. View abstract
  185. Benign pneumatosis intestinalis with subcutaneous emphysema in a liver transplant recipient. Am J Gastroenterol. 1990 Jul; 85(7):876-9. View abstract
  186. Hepatitis B infection in a large municipal obstetrical population: characterization and prevention of perinatal transmission. Am J Gastroenterol. 1990 Mar; 85(3):277-80. View abstract
  187. Current trends in immunosuppression in pediatric orthotopic liver transplantation. Internat Pediatr. 1990; 5:18-22. View abstract
  188. Histopathologic features of the liver in pediatric acquired immune deficiency syndrome. J Pediatr Gastroenterol Nutr. 1989 Jul; 9(1):73-81. View abstract
  189. Gastrointestinal disease symptoms. Curr Opin Pediatr. 1989; 1:345-9. View abstract
  190. Isolated intestinal myopathy resembling progressive systemic sclerosis in a child. Gastroenterology. 1988 Oct; 95(4):1114-8. View abstract
  191. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr. 1988 Sep-Oct; 7(5):776-9. View abstract
  192. Neonatal hemochromatosis: failure of deferoxamine therapy. J Pediatr Gastroenterol Nutr. 1987 Nov-Dec; 6(6):984-8. View abstract
  193. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987 Sep; 107(3):335-7. View abstract
  194. Inflammatory bowel disease in children and adolescents. Pract Gastroenterol. 1987; 11:37-42. View abstract
  195. Intestinal lactase synthesis during postnatal development in the rat. Pediatr Res. 1985 Sep; 19(9):956-62. View abstract
  196. The abdomen and gastrointestinal tract (sections). Pediatrics (M Ziai, ed.). 1984; 292-4. View abstract
  197. Clinical response to penicillamine in cholestatic liver disease. Extrahepatic biliary atresia (F Daum, ed.). 1983; 227-32. View abstract
  198. Intestinal disaccharidases: structure, function and deficiency. Carbohydrate intolerance in infancy (F Lifshitz, ed.). 1982; 75-92. View abstract